...
首页> 外文期刊>Journal of vascular surgery >Combination of a clinical risk assessment score and rapid whole blood D-dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients.
【24h】

Combination of a clinical risk assessment score and rapid whole blood D-dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients.

机译:临床风险评估评分与快速全血D-二聚体检测相结合,可用于有症状患者的深静脉血栓形成诊断。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: The clinical diagnosis of deep vein thrombosis (DVT) is unreliable in more than 50% of cases, and, in recent years, plasma D-dimer assays have been used to predict the presence of DVT with high sensitivity and negative predictive values. This study investigated the use of a rapid whole blood test that could be performed and interpreted by the bedside in addition to a clinically derived risk assessment score (RAS) to determine whether a practical and cost-effective clinical model could be developed for the diagnosis and exclusion of DVT in symptomatic patients. METHODS: Two hundred consecutive patients who were referred to the vascular laboratory with clinically suspected DVT underwent the following procedures: (1) clinical assessment and stratification into low, moderate, or high risk for DVT on the basis of an RAS related to history, symptoms, and physical examination findings; (2) rapid (5-minute) whole blood D-dimer testing with a semi-qualitative agglutination technique on a fingerprick blood sample; and (3) color flow duplex ultrasound scanning with standard criteria for the diagnosis of proximal and calf DVT. RESULTS: Forty-six patients (23%) had acute DVT on duplex ultrasound scanning. Of these cases, 28 (61%) had proximal DVT and 18 (39%) were confined to the calf. A total of 88 patients were classified as low risk, 67 were classified as moderate, and 45 were classified as high risk on the basis of the RAS method. Of the patients who were classified at low risk, 4.5% (4/88) had DVT, as compared with 17.9% (12/67) in the moderate clinical risk group and 66.7% (30/45) in the high risk group. Isolated calf DVT was found in 30% (9/30), 50% (6/12), and 75% (3/4) of the high, moderate, and low risk groups, respectively. The sensitivity (8.7%, 26.1%, 65.2%), specificity (45.5%, 64.3%, 90.3%), positive predictive value (4.5%, 17.9%, 66.7%), and overall accuracy rate (37%, 55.5%, 84.5%) of the low, moderate, and high risk groups, respectively, in the diagnosis of DVT increased significantly with increasing risk score stratification. The sensitivity, specificity, positive and negative predictive value, and overall accuracy of the rapid D-dimer test for all DVT were 91.3%, 81.9%, 60%, 96.9%, and 84%, respectively, with a 100% sensitivity and negative predictive value for proximal DVT. A combination of the RAS and D-dimer identified a low risk group with a negative D-dimer as having less than a 1% likelihood of DVT and a high risk group with positive D-dimer as having a likelihood of more than 90%. CONCLUSION: A combination of clinical assessment and rapid D-dimer testing provides an effective means of excluding proximal DVT in symptomatic patients. The application of a clinical diagnostic model on the basis of these parameters has the potential for saving a large proportion of unnecessary duplex scans with the associated time and costs.
机译:目的:在超过50%的病例中,对深静脉血栓形成(DVT)的临床诊断并不可靠,并且近年来,血浆D-二聚体测定已被用于以高灵敏度和阴性预测值预测DVT的存在。这项研究调查了除临床上衍生的风险评估评分(RAS)之外,还可以在床旁进行快速全血检测的方法,以确定是否可以开发出实用且具有成本效益的临床模型进行诊断和诊断。在有症状的患者中排除DVT。方法:连续200例因临床怀疑DVT而被转诊至血管实验室的患者接受以下程序:(1)根据与病史,症状相关的RAS,对DVT的临床评估和分层分为低,中或高风险以及体格检查结果; (2)用半定性凝集技术对指尖血液样品进行快速(5分钟)全血D-二聚体检测; (3)使用标准标准的彩色流双工超声扫描来诊断近端和小腿DVT。结果:46例患者(23%)在双工超声扫描中患有急性DVT。其中28例(61%)有近端DVT,18例(39%)局限于小腿。根据RAS方法,共有88例患者被归为低危,67例被归为中危,45例被归为高危。在低危患者中,DVT占4.5%(4/88),中度临床风险组为17.9%(12/67),高风险组为66.7%(30/45)。高,中,低风险组分别有30%(9/30),50%(6/12)和75%(3/4)的小牛DVT。敏感性(8.7%,26.1%,65.2%),特异性(45.5%,64.3%,90.3%),阳性预测值(4.5%,17.9%,66.7%)和总体准确率(37%,55.5%,在DVT的诊断中,低,中和高风险组分别有84.5%)随着风险评分分层的增加而显着增加。快速D-二聚体检测对所有DVT的敏感性,特异性,阳性和阴性预测值以及整体准确性分别为91.3%,81.9%,60%,96.9%和84%,敏感性为100%,阴性DVT的预测价值。 RAS和D-二聚体的组合确定了D-二聚体阴性的低风险组的DVT可能性小于1%,D-二聚体阳性的高风险组的可能性大于90%。结论:结合临床评估和快速D-二聚体检测可为有症状患者排除近端DVT提供有效的手段。基于这些参数的临床诊断模型的应用具有节省大量不必要的双面扫描以及相关时间和成本的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号